Overexpression of TRIM44 is an independent marker for predicting poor prognosis in epithelial ovarian cancer.

Liu, Shuang; Yin, Hexuan; Ji, Hongying; Zhu, Jiaqi; Ma, Rong

Liu, Shuang; Yin, Hexuan; Ji, Hongying; Zhu, Jiaqi; Ma, Rong.

Afiliação

Liu S; Department of Gynaecology and Obstetrics, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, P.R. China.
Yin H; Department of Gynaecology and Obstetrics, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, P.R. China.
Ji H; Department of Gynaecology and Obstetrics, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, P.R. China.
Zhu J; Department of Gynaecology and Obstetrics, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, P.R. China.
Ma R; Department of Gynaecology and Obstetrics, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, P.R. China.

Exp Ther Med ; 16(4): 3034-3040, 2018 Oct.

Article em En | MEDLINE | ID: mdl-30214522

Palavras-chave

epithelial ovarian cancer; metastasis; prognosis; tripartite motif-containing protein 44

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Exp Ther Med Ano de publicação: 2018 Tipo de documento: Article País de publicação: Grécia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google